Smouldering myeloma: detection, risk stratification and defining a new standard of care
Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss
Refining and improving treatment options in CLL
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
The success story of indolent disease treatment expanded to difficult-to-treat patient groups